Melanoma | Breakfast with the Investigators: Management of Melanoma

1:02:00
 
Share
 

Manage episode 238209949 series 1464173
By Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio streamed directly from their servers.

Proceedings from a CME symposium held at the 2019 ASCO Annual Meeting. Featuring perspectives from Prof Georgina Long and Drs Jason J Luke and Jeffrey S Weber.

  • Introduction (00:00)
    • Program overview: Dr Love
  • Adjuvant Systemic Therapy of Melanoma (1:33)
  • Case (Dr Weber): A man in his early 50s with melanoma and a BRAF V600E tumor mutation who received adjuvant dabrafenib/trametinib (7:20)
  • Case (Prof Long): A man in his mid-60s with BRAF wild-type melanoma who developed a local recurrence after adjuvant nivolumab (9:28)
  • Case (Dr Luke): A woman in her mid-40s with BRAF wild-type melanoma who received adjuvant nivolumab and developed immune-related hypothyroidism (15:22)
  • BRAF/MEK Inhibitor Combinations in the Management of Metastatic Melanoma (24:52)
  • Case (Prof Long): A woman in her mid-70s with newly diagnosed metastatic melanoma and a BRAF V600K tumor mutation who received encorafenib/binimetinib (37:40)
  • Case (Dr Luke): A man in his mid-50s with metastatic melanoma and a BRAF tumor mutation who developed brain metastases (42:02)
  • Immune Checkpoint Inhibitors in the Management of Metastatic Melanoma (48:25)
  • Case (Dr Weber): A man in his late 30s with metastatic BRAF wild-type melanoma, including brain metastases, who experienced disease progression on single-agent anti-PD-1 antibody therapy and was switched to nivolumab/ipilimumab (50:22)

Select publications

2175 episodes available. A new episode about every 2 days averaging 75 mins duration .